Note: Arnet Pharmaceutical's revenues are gauged from an analysis of company filings.
Arnet Pharmaceutical's Income Statement (based on Industry Averages)
Arnet Pharmaceutical P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Arnet Pharmaceutical is developing and marketing.
Arnet Pharmaceutical doesn't have any recent trademark applications, indicating Arnet Pharmaceutical is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SUPPLEVETS Vitamins for pets
06/19/2018
DR MAX Dietary and nutritional supplements manufactured in the United States for export only
03/27/2017
VITA-VIGOR Dietary and nutritional supplements
10/05/2012
See all trademarks and details in the Full Report.
Market Share of Arnet Pharmaceutical's Largest Competitors
A competitive analysis shows these companies are in the same general field as Arnet Pharmaceutical, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Arnet Pharmaceutical.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Arnet Pharmaceutical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.